A detailed history of Numerai Gp LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Numerai Gp LLC holds 15,079 shares of HAE stock, worth $1.35 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
15,079
Previous 3,802 296.61%
Holding current value
$1.35 Million
Previous $315 Million 285.34%
% of portfolio
0.32%
Previous 0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.45 - $91.58 $817,018 - $1.03 Million
11,277 Added 296.61%
15,079 $1.21 Billion
Q2 2024

Aug 14, 2024

BUY
$81.24 - $97.37 $308,874 - $370,200
3,802 New
3,802 $315 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.58B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Numerai Gp LLC Portfolio

Follow Numerai Gp LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Numerai Gp LLC, based on Form 13F filings with the SEC.

News

Stay updated on Numerai Gp LLC with notifications on news.